Related Experiment Video
Updated: Mar 27, 2026

11:24
Measuring DNA Damage and Repair in Mouse Splenocytes After Chronic In Vivo Exposure to Very Low Doses of Beta- and Gamma-Radiation
Published on: July 3, 2015
11.6K
Argemone oil induces genotoxicity in mice
Ilika Ghosh1, Anita Mukherjee1
1a Cell Biology and Genetic Toxicology Laboratory, Department of Botany, Centre of Advance Study, University of Calcutta , Kolkata , India.
Drug and Chemical Toxicology
|January 14, 2016
Summary
Argemone oil (AO) is genotoxic, causing DNA damage at low doses. This study confirms AO
Area of Science:
- Toxicology
- Genetics
- Pharmacology
Background:
- Argemone mexicana L. (AO) is used in traditional medicine but is a common adulterant of mustard oil.
- AO adulteration causes epidemic dropsy, with limited in vivo genotoxicity data.
- This study investigates the genotoxic potential of AO in mice.
Purpose of the Study:
- Evaluate the in vivo genotoxic potential of Argemone oil (AO).
- Assess the safety of AO by examining its effects on bone marrow cells.
- Determine the genotoxicity of AO and its alkaloid sanguinarine.
Main Methods:
- Administered varying doses of AO and sanguinarine (SG) intraperitoneally to male Swiss Albino mice.
- Assessed genotoxicity using chromosome aberration (CA) and sister chromatid exchange (SCE) tests.
- Evaluated cell replication effects using Bromodeoxyuridine (BrdU) and average generation time (AGT).
Main Results:
- Significant frequencies of CA and SCE were observed at low AO concentrations (0.1 and 0.01 ml/kg, respectively).
- AO and SG induced an insignificant increase in AGT, suggesting they are non-cytotoxic at tested concentrations.
- Genotoxicity was confirmed even at low doses of AO.
Conclusions:
- Argemone oil (AO) demonstrates genotoxic effects at low concentrations.
- The study confirms AO's genotoxicity, necessitating caution regarding its use.
- Further research is needed to understand the full toxicological profile of AO.
Related Concept Videos
Mutagenicity and Carcinogenicity
2.1K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.1K
In vitro Mutagenesis
5.5K
5.5K
In-vitro Mutagenesis
17.6K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
17.6K

